메뉴 건너뛰기




Volumn 23, Issue 1, 2014, Pages 2-9

The current and future role of the novel oral anticoagulants-indications beyond atrial fibrillation

Author keywords

Anticoagulation; Apixaban; Dabigatran; Edoxaban; Rivaroxaban; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; APIXABAN; CLOPIDOGREL; DABIGATRAN; EDOXABAN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; PRASUGREL; RIVAROXABAN; TICAGRELOR; WARFARIN;

EID: 84891825914     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2013.09.007     Document Type: Review
Times cited : (7)

References (45)
  • 1
    • 84859603846 scopus 로고    scopus 로고
    • New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease position paper
    • De Caterina R., Husted S., Wallentin L., Andreotti F., Arnesen H., Bachmann F., et al. New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease position paper. J Am Coll Cardiol 2012, 59:1413-1425.
    • (2012) J Am Coll Cardiol , vol.59 , pp. 1413-1425
    • De Caterina, R.1    Husted, S.2    Wallentin, L.3    Andreotti, F.4    Arnesen, H.5    Bachmann, F.6
  • 2
    • 84863814810 scopus 로고    scopus 로고
    • Novel anticoagulants for non-valvular atrial fibrillation
    • Xu B., Whitbourn R. Novel anticoagulants for non-valvular atrial fibrillation. Heart Lung Circ 2012, 21:463-467.
    • (2012) Heart Lung Circ , vol.21 , pp. 463-467
    • Xu, B.1    Whitbourn, R.2
  • 3
    • 84891830360 scopus 로고    scopus 로고
    • Australian Register of Therapeutic Goods Public Summary - PRADAXA dabigatran etexilate 150mg. Available at: [accessed 07.09.13].
    • Australian Register of Therapeutic Goods Public Summary - PRADAXA dabigatran etexilate 150mg. Available at: [accessed 07.09.13]. http://www.ebs.tga.gov.au/servlet/xmlmillr6%3Fdbid=ebs/PublicHTML/pdfStore.nsf%26docid=488D5196B9F531F5CA257BB80042315D%26agid=(PrintDetailsPublic)%26actionid=1.
  • 4
    • 84891837111 scopus 로고    scopus 로고
    • Australian Register of Therapeutic Goods Public Summary - XARELTO rivaroxaban 20mg. Available at: [accessed 07.09.13].
    • Australian Register of Therapeutic Goods Public Summary - XARELTO rivaroxaban 20mg. Available at: [accessed 07.09.13]. http://www.ebs.tga.gov.au/servlet/xmlmillr6%3Fdbid=ebs/PublicHTML/pdfStore.nsf%26docid=1A8B73A173BCCFA0CA257B9C007EDC63%26agid=(PrintDetailsPublic)%26actionid=1.
  • 5
    • 84891832539 scopus 로고    scopus 로고
    • Australian Register of Therapeutic Goods Public Summary - ELIQUIS. Available at: [accessed 07.09.13].
    • Australian Register of Therapeutic Goods Public Summary - ELIQUIS. Available at: [accessed 07.09.13]. http://www.ebs.tga.gov.au/servlet/xmlmillr6%3Fdbid=ebs/PublicHTML/pdfStore.nsf%26docid=944549A4FCA15D97CA257BA900423723%26agid=(PrintDetailsPublic)%26actionid=1.
  • 6
    • 84891831981 scopus 로고    scopus 로고
    • Pharmaceutical Benefits Scheme (PBS) - DABIGATRAN. Available at: [accessed 07.09.13].
    • Pharmaceutical Benefits Scheme (PBS) - DABIGATRAN. Available at: [accessed 07.09.13]. http://www.pbs.gov.au/medicine/item/2769R.
  • 7
    • 84891830819 scopus 로고    scopus 로고
    • Pharmaceutical Benefits Scheme (PBS) - RIVAROXABAN. Available at: [accessed 07.09.13].
    • Pharmaceutical Benefits Scheme (PBS) - RIVAROXABAN. Available at: [accessed 07.09.13]. http://www.pbs.gov.au/medicine/item/2268J.
  • 8
    • 84891826958 scopus 로고    scopus 로고
    • Pharmaceutical Benefits Scheme (PBS) - APIXABAN. Available at: [accessed 07.09.13].
    • Pharmaceutical Benefits Scheme (PBS) - APIXABAN. Available at: [accessed 07.09.13]. http://www.pbs.gov.au/medicine/item/2735Y.
  • 9
    • 84891832867 scopus 로고    scopus 로고
    • FDA approves Pradaxa to prevent stroke in people with atrial fibrillation. Available at: [accessed 07.09.13].
    • FDA approves Pradaxa to prevent stroke in people with atrial fibrillation. Available at: [accessed 07.09.13]. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm230241.htm.
  • 10
    • 84891835456 scopus 로고    scopus 로고
    • FDA approves Xarelto to prevent stroke in people with common type of abnormal heart rhythm. Available at: [accessed 07.09.13].
    • FDA approves Xarelto to prevent stroke in people with common type of abnormal heart rhythm. Available at: [accessed 07.09.13]. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm278646.htm.
  • 11
    • 84891832668 scopus 로고    scopus 로고
    • FDA approves Eliquis to reduce the risk of stroke, blood clots in patients with non-valvular atrial fibrillation. Available at: [accessed 07.09.13].
    • FDA approves Eliquis to reduce the risk of stroke, blood clots in patients with non-valvular atrial fibrillation. Available at: [accessed 07.09.13]. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm333634.htm.
  • 12
    • 84891833285 scopus 로고    scopus 로고
    • European Medicines Agency - Find medicine - Pradaxa. Available at: [accessed 07.09.13].
    • European Medicines Agency - Find medicine - Pradaxa. Available at: [accessed 07.09.13]. http://www.emea.europa.eu/ema/index.jsp%3Fcurl=pages/medicines/human/medicines/000829/human_med_000981.jsp%26mid=WC0b01ac058001d124.
  • 13
    • 84891832261 scopus 로고    scopus 로고
    • European Medicines Agency - Find medicine - Xarelto. Available at: [accessed 07.09.13].
    • European Medicines Agency - Find medicine - Xarelto. Available at: [accessed 07.09.13]. http://www.ema.europa.eu/ema/index.jsp%3Fcurl=pages/medicines/human/medicines/000944/human_med_001155.jsp%26mid=WC0b01ac058001d124.
  • 14
    • 84891829470 scopus 로고    scopus 로고
    • ELIQUIS®(apixaban) approved in Europe for prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. Available at: [accessed 07.09.13].
    • ELIQUIS®(apixaban) approved in Europe for prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. Available at: [accessed 07.09.13]. http://news.bms.com/press-release/financial-news/eliquisapixaban-approved-europe-prevention-stroke-and-systemic-embolism%26t=634890181706594412.
  • 15
    • 77957932391 scopus 로고    scopus 로고
    • Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction study 48 (ENGAGE AF-TIMI 48)
    • Ruff C.T., Giugliano R.P., Antman E.M., Crugnale S.E., Bocanegra T., Mercuri M., et al. Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction study 48 (ENGAGE AF-TIMI 48). Am Heart J 2010, 160:635-641.
    • (2010) Am Heart J , vol.160 , pp. 635-641
    • Ruff, C.T.1    Giugliano, R.P.2    Antman, E.M.3    Crugnale, S.E.4    Bocanegra, T.5    Mercuri, M.6
  • 16
    • 79960261824 scopus 로고    scopus 로고
    • Guidelines on oral anticoagulation with warfarin - fourth edition
    • Keeling D., Baglin T., Tait C., Watson H., Perry D., Baglin C., et al. Guidelines on oral anticoagulation with warfarin - fourth edition. Br J Haematol 2011, 154:311-324.
    • (2011) Br J Haematol , vol.154 , pp. 311-324
    • Keeling, D.1    Baglin, T.2    Tait, C.3    Watson, H.4    Perry, D.5    Baglin, C.6
  • 18
    • 33645229796 scopus 로고    scopus 로고
    • Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients
    • Andreotti F., Testa L., Biondi-Zoccari G.G., Crea F. Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients. Eur Heart J 2006, 27:519-526.
    • (2006) Eur Heart J , vol.27 , pp. 519-526
    • Andreotti, F.1    Testa, L.2    Biondi-Zoccari, G.G.3    Crea, F.4
  • 20
    • 84891826663 scopus 로고    scopus 로고
    • A randomized trial of dabigatran versus warfarin in the treatment of acute venous thromboembolism (RE-COVER II). American Society of Hematology 2011 Annual Meeting. December 12, San Diego, CA, USA. Abstract 2005
    • Schulman S, Kakkar AK, Schellong SM, Goldhaber SZ, Henry E, Mismetti P, et al. A randomized trial of dabigatran versus warfarin in the treatment of acute venous thromboembolism (RE-COVER II). American Society of Hematology 2011 Annual Meeting. December 12, San Diego, CA, USA. Abstract 2005; 2011.
    • (2011)
    • Schulman, S.1    Kakkar, A.K.2    Schellong, S.M.3    Goldhaber, S.Z.4    Henry, E.5    Mismetti, P.6
  • 24
    • 79961199378 scopus 로고    scopus 로고
    • Oral rivaroxaban after symptomatic venous thromboembolism: the continued treatment study (EINSTEIN-Extension study)
    • Romualdi E., Donadini M.P., Ageno W. Oral rivaroxaban after symptomatic venous thromboembolism: the continued treatment study (EINSTEIN-Extension study). Expert Rev Cardiovasc Ther 2011, 9:841-844.
    • (2011) Expert Rev Cardiovasc Ther , vol.9 , pp. 841-844
    • Romualdi, E.1    Donadini, M.P.2    Ageno, W.3
  • 25
    • 84880327613 scopus 로고    scopus 로고
    • Oral apixaban for the treatment of acute venous thromboembolism
    • [Epub ahead of print]
    • Agnelli G., Buller H.R., Cohen A., Curto M., Gallus A.S., Johnson M., et al. Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med 2013, [Epub ahead of print]. 10.1056/NEJMoa1302507.
    • (2013) N Engl J Med
    • Agnelli, G.1    Buller, H.R.2    Cohen, A.3    Curto, M.4    Gallus, A.S.5    Johnson, M.6
  • 28
    • 80052232522 scopus 로고    scopus 로고
    • Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial
    • Oldgren J., Budaj A., Granger C.B., Khder Y., Roberts J., Siegbahn A., et al. Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial. Eur Heart J 2011, 32:2781-2789.
    • (2011) Eur Heart J , vol.32 , pp. 2781-2789
    • Oldgren, J.1    Budaj, A.2    Granger, C.B.3    Khder, Y.4    Roberts, J.5    Siegbahn, A.6
  • 30
    • 84857021520 scopus 로고    scopus 로고
    • Dabigatran association with higher risk of acute coronary events
    • Uchino K., Hernandez A.V. Dabigatran association with higher risk of acute coronary events. Arch Intern Med 2012, 172:397-402.
    • (2012) Arch Intern Med , vol.172 , pp. 397-402
    • Uchino, K.1    Hernandez, A.V.2
  • 35
    • 84866368808 scopus 로고    scopus 로고
    • ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update)
    • Jneid H., Anderson J.L., Wright R.S., Adams C.D., Bridges C.R., Casey D.E., et al. ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update). J Am Coll Cardiol 2012, 60:645-681.
    • (2012) J Am Coll Cardiol , vol.60 , pp. 645-681
    • Jneid, H.1    Anderson, J.L.2    Wright, R.S.3    Adams, C.D.4    Bridges, C.R.5    Casey, D.E.6
  • 36
    • 84866732231 scopus 로고    scopus 로고
    • ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
    • Steg P.G., James S.K., Atar D., Badano L.P., Lundgvist C.B., Borger M.A., et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012, 33:2569-2619.
    • (2012) Eur Heart J , vol.33 , pp. 2569-2619
    • Steg, P.G.1    James, S.K.2    Atar, D.3    Badano, L.P.4    Lundgvist, C.B.5    Borger, M.A.6
  • 37
    • 84856158305 scopus 로고    scopus 로고
    • ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
    • Hamm C.W., Bassand J.P., Agewall S., Bax J., Boersma E., Bueno H., et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2011, 32:2999-3054.
    • (2011) Eur Heart J , vol.32 , pp. 2999-3054
    • Hamm, C.W.1    Bassand, J.P.2    Agewall, S.3    Bax, J.4    Boersma, E.5    Bueno, H.6
  • 39
    • 77956899158 scopus 로고    scopus 로고
    • Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation
    • Hansen M.L., Sorensen R., Clausen M.T., Fog-Petersen M.L., Raunso J., Gadsboll N., et al. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. Arch Intern Med 2010, 170:1433-1441.
    • (2010) Arch Intern Med , vol.170 , pp. 1433-1441
    • Hansen, M.L.1    Sorensen, R.2    Clausen, M.T.3    Fog-Petersen, M.L.4    Raunso, J.5    Gadsboll, N.6
  • 40
    • 84875720372 scopus 로고    scopus 로고
    • Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial
    • Dedilde W.J.M., Oirbans T., Verheugt F.W.A., Kelder J.C., De Smet B.J.G.L., Herrman J.-P., et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet 2013, 381:1107-1115.
    • (2013) Lancet , vol.381 , pp. 1107-1115
    • Dedilde, W.J.M.1    Oirbans, T.2    Verheugt, F.W.A.3    Kelder, J.C.4    De Smet, B.J.G.L.5    Herrman, J.-P.6
  • 41
    • 84855851690 scopus 로고    scopus 로고
    • Thrombosis on a mechanical aortic valve whilst anti-coagulated with dabigatran
    • Stewart R.A., Astell H., Young L., White H.D. Thrombosis on a mechanical aortic valve whilst anti-coagulated with dabigatran. Heart Lung Circ 2012, 21:53-55.
    • (2012) Heart Lung Circ , vol.21 , pp. 53-55
    • Stewart, R.A.1    Astell, H.2    Young, L.3    White, H.D.4
  • 43
    • 84865657840 scopus 로고    scopus 로고
    • Thrombosis of a mechanical heart valve despite dabigatran
    • Chu J.W., Chen V.H., Bunton R. Thrombosis of a mechanical heart valve despite dabigatran. Ann Intern Med 2012, 157:304.
    • (2012) Ann Intern Med , vol.157 , pp. 304
    • Chu, J.W.1    Chen, V.H.2    Bunton, R.3
  • 45
    • 84891834120 scopus 로고    scopus 로고
    • Boehringer Ingelheim discontinues Phase II trial in patients with artificial heart valves. Available at: [accessed 07.09.13].
    • Boehringer Ingelheim discontinues Phase II trial in patients with artificial heart valves. Available at: [accessed 07.09.13]. http://www.boehringer-ingelheim.com/news/news_releases/press_releases/2012/11_december_2012dabigatranetexilate1.html.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.